INHERIT/REVEAL
LIVE

Serial Number

88910401

Owner

Pillar Biosciences, Inc.

Attorney

Marcus Assefa

First Use Date

Nov 23, 2020

Filing Date

May 11, 2020

Add to watchlist:

No watchlists yet
View on USPTO

INHERIT/REVEAL Trademark

Serial Number: 88910401 • Registration: 6472132

INHERIT/REVEAL is a trademark filed by Pillar Biosciences, Inc. on May 11, 2020. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Pillar Biosciences, Inc. (17 trademarks)

Natick, MA 01760

Entity Type: 03

Trademark Details

Filing Date

May 11, 2020

Registration Date

August 31, 2021

First Use Anywhere

November 23, 2020

First Use in Commerce

November 23, 2020

Published for Opposition

September 8, 2020

Goods & Services

Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research

Software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; software as a service (Saas), namely, hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; scientific research, namely, collection, management, and analysis of data in the fields of scientific research, clinical research and scientific diagnostics; providing biological sample testing services for others in the fields of scientific research, clinical research and scientific diagnostics; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, and scientific diagnostics research; genetic testing for scientific research purposes in the nature of providing bioinformatics and gene expression microarray image analysis services for others, namely, performing gene expression quantification, gene image processing, and gene information processing for others; medical diagnostic research, namely, collection, management, and analysis of data in the field of medical diagnostics

Filing History

REGISTERED-PRINCIPAL REGISTER
Aug 31, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 28, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 27, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2021 CRFA
ASSIGNED TO LIE
Jul 2, 2021 ALIE
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
May 10, 2021 SUPC
SOU EXTENSION 1 GRANTED
May 10, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 10, 2021 AITU
USE AMENDMENT FILED
Apr 30, 2021 IUAF
SOU EXTENSION 1 FILED
Apr 30, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 30, 2021 EEXT
TEAS STATEMENT OF USE RECEIVED
Apr 30, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 3, 2020 NOAM
ASSIGNED TO EXAMINER
Oct 20, 2020 DOCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2020 CNSA
ASSIGNED TO EXAMINER
Aug 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 21, 2020 NWOS
NEW APPLICATION ENTERED
May 14, 2020 NWAP